Prevalence of HIV, HCV and other sexually transmitted infections and associated risk behaviours among Spanish and immigrant IDU in Catalonia, Spain

Similar documents
High prevalence and incidence of HIV and HCV among new injecting drug users with a large proportion of migrants Is prevention failing?

Differences by country of origin and by gender among people who inject drugs attending low threshold agencies in Catalonia

Public drug policies Catalonia

One-step screening of active hepatitis C virus infection in the community through dried blood spots

Measurement of sexual health outcomes among people who inject drugs: pilot study in Catalonia, Spain and Barnaul, Russia

Strategies of drug users to avoid infection with hepatitis C

Harm reduction among drug users in Spain

AUSTRALIAN NSP SURVEY NATIONAL DATA REPORT

Prevalence of HIV and risk behaviors among injecting drug users in Tallinn, Estonia in a series of cross-sectional studies

Additional North Carolina Projects

PERFORMANCE AND IMAGE ENHANCING DRUGS

Improving Access to Test and Counselling Services for Injection Drug Users: Most Recent Experience from Portugal. Henrique Barros

Saskatchewan HIV Strategy: Social Network Approach

Poland nationalupdate

HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications

Harm Reduction Database Wales: Needle and Syringe provision

New Brunswick Report on Sexually Transmitted and Blood Borne Infections, 2016


The new German strategy on HIV, Hepatitis B, C and STI, an integrated approach. Ines Perea Ministry of Health, Germany

Sexual Partners and Condom Use Attitude: Qualitative Findings among Injecting Drug Users in Hai Phong, Vietnam

Thirty years of harm reduction in the Netherlands HCV elimination ahead?

HIV Risk Behaviour in Irish Intravenous Drug Users

Hepatitis prevention in the context of HIV prevention point work in Latvia

Prevention services for minors in prisons

Dr Vivian Hope. Health Protection Agency, London. 19 th Annual Conference of the British HIV Association (BHIVA)

PrEP Home Checklist v1.0

Background Past Present Future

Government of Canada Federal AIDS Initiative Milestones

The Integrated Bio Behavioural Surveillance (IBBS) Survey 2009 Malaysia: Preliminary Findings

M. Vall-Mayans a, *, M. Villa b, M. Saravanya a, E. Loureiro a, M. Meroño c, E. Arellano a, B. Sanz a, P. Saladié a, A. Andreu b, M.G.

Signs of success latest national NESI data?

Prevention and control of Hepatitis B and C among vulnerable groups Estonia: People who use drugs

Drug using mothers: retaining care of their children

Methods: respondent driven sampling (RDS) was used to recruit PWID

Sexual relationships, risk behaviour, and condom

Please note: If you filled in the form during a previous visit, you must not fill it in again!

First results collected by Argos, DCR in Strasbourg opened in november 2016

Young People and HIV/AIDS

I TRACK Survey. Report June 1, 2006

As a result of this training, participants will be able to:

Australian Research Centre in Sex, Health & Society. EMBARGOED until am 4/8/09 Secondary Students and Sexual Health 2008

Gay Community Periodic Survey: Canberra 2015

National HIV Behavioral Surveillance Portland, Oregon

Gay Community Periodic Survey: Melbourne 2017

Annual Reports Questionnaire (ARQ) Part III: Extent, patterns and trends in drug use

Dr. dr. Diah Setia Utami, SpKJ, MARS Deputy of Rehabilitation Narcotic National Board of Republic of Indonesia

EMCDDA-update HIV/HCV among people who inject drugs: situation and response

Sexually Transmitted Infections in Vulnerable Groups. Kevin Rebe

THE REPUBLIC OF BELARUS

Summary Report - IBBS Balochistan - Quetta Round 1, ROUND 1 SUMMARY REPORT -BALOCHISTAN QUETTA

From Fix to Foil. The Dutch experience in promoting transition away from injecting drug use,

Methadone Treatment as a Harm Reduction Strategy, Gender Sensitive Programming and Evidence-based Strategies

The Comprehensive Package: The simple truth about our response to drug related HIV. Dr. Monica Beg, Signe Rotberga UNODC

The role of UNODC in working law enforcement agencies to promote harm reduction. IHRC, Bangkok, 23 April 2009

Gay Community Periodic Survey Canberra 2011

South Asian Cocktail The Predominant Drug Use Pattern in Nepal and its Association with Spread of HIV

New South Wales Needle and Syringe Program Enhanced Data Collection

UNGASS Declaration of Commitment on HIV/AIDS: Core Indicators revision

COUNTRY TABLE. MONTENEGRO.

INTRAVENOUS INJECTING DRUG USE.

WHITEHORSE I-TRACK REPORT. Monitoring Risk Behaviour among People Who Inject or Inhale Drugs in Whitehorse, Yukon

Formative Research results

Part of the Continuum of Care. Harm Reduction. Gino Vumbaca President Harm Reduction Australia

Update Report # 45. Patterns of Sexual Behaviors and Sexual Risk among HIV Positive People in New York City

China Country Advocacy Brief Injecting Drug Use and HIV

Promoting hepatitis B vaccination

Technical Guidance Note for Global Fund HIV Proposals

Gay Community Periodic Survey: Perth 2016

Blood-borne viruses in marginalised populations

Strategies to Reduce Harm and HIV/AIDS Infection among Drug Using Populations

Harm Reduction in Nigeria

Co-Variation in Sexual and Non-Sexual Risk Behaviors Over Time Among U.S. High School Students:

Overview of Syringe Exchange Programs. New York City Police Academy November 24, 2004

2 nd Meeting on detecting and responding to outbreaks of HIV among PWID

As a result of this training, participants will be able to:

HIV EPIDEMIC UPDATE: FACTS & FIGURES 2012

CONFERENCES CYCLE IN ENGLISH (1 st edition) Dr. Elisabet Vilella Pharmacogenomics and Genetics Unitat de Recerca. Hospital Pere Mata.

Detection of Hepatitis B and C in Primary Care

Prevention and care towards vulnerable and stigmatized populations (MSM, drug users, sex workers)

STIs and BBVs. The facts

Glossary of Acronyms. AIDS - Acquired Immunodeficiency Syndrome. CDC - Centers for Disease Control and Prevention. DHS - Department of Health Services

UNGASS Indicators and possible adoption of NDPHS indicators. Tallinn /P.Leinikki

Survey questionnaire on STI. surveillance, care and prevention. in European countries SAMPLE APPENDIX

HIV/AIDS Prevalence Among South African Health Workers, 2002

Review on HIV & Associated Infections in Latvia

HIV/AIDS INDICATORS. AIDS Indicator Survey 8 Basic Documentation Introduction to the AIS

Drug consumption among roma population

Characteristics of cases of infectious syphilis diagnosed in prisons,

UNAIDS 99.1E (English original, March 1999) This document, presenting a speech given at the United Nations General Assembly Special Session on Drugs,

Key words: YIDUs, condom use behaviour

Sexually Transmitted Infection, including HIV, Health Protection Scotland Slide Set

DEPARTMENT OF HEALTH RESPONSE TO KEY POPULATIONS

AUSTRALIAN NSP SURVEY

Global AIDS Response Progress Report Myanmar. National AIDS Programme

59 th Session of Commission on Narcotic Drugs Vienna 14-22March 2016

Testing, Prevention and Care IDU in Chicago, 2009

Groups of young people in Uganda that need to be targeted with HIV interventions

Narrative report of HIV Preventive programmes in the Slovak Republic as of 31-st December 2013

Responsibilities in a sexual relationship - Contact tracing

U.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs

Transcription:

Prevalence of HIV, HCV and other sexually transmitted infections and associated risk behaviours among Spanish and immigrant IDU in Catalonia, Spain Folch C, Casabona J, Majó X, Brugal T, Meroño M, González V, and Working group REDAN IHRA s 21st International Conference. Liverpool 26 April 21

Where is Catalonia? Barcelona

Background In Catalonia foreign population in 2 accounted for less than 3 of the overall population and in 29 that percentage had increased up to 16. We have also observed an increase of the immigrant UDIs which probably have a greater vulnerability to infections due to risk factors such as marginality, social exclusion and low contact with drug and health services. IDUs in Catalonia have still a high HIV prevalence due to the dramatic epidemic in the late 8s. This along with a still high sexual risk behaviour makes knowing the ITS prevalence an important objective in order to decrease HIV and ITS transmission

Aims To describe HIV, HCV, Chlamydia trachomatis and Neisseria gonorrhoeae prevalences among IDUs recruited in Catalonia To describe Risk behaviour prevalences related to these infections To compare HIV, HVC and ITS and risk behaviour prevalences between Spanish and Immigrant drug injectors

Methodology 748 UDIs recruited from Harm Reduction Services in Catalonia October 28 December 29 Stratified sample by service and country Inclusion criterion: current injectors (Last 6 months) Anonymous interview with a structured questionnaire Collection of biological samples VIH and VHC C. Trachomatis and N. gonorrhoeae

Results Sample breakdown by country 7, 6, 58,7 5, 4, 3, 23,5 2, 1, 9,2 6,6,,8,1 1,1

Sociodemographics: Spanish n=439 Immigrants n=39 Total p Mean age (DE) 38,5 (7,1) 33,4 (6,9) 36,4 (7,5) <,1 Men 78,1 88, 82,2 <,1 Living in Barcelona 8, 95,1 86,2 <,1 University degrees 1,1 18,3 8,2 <,1 Working situation*: <,1 Working 22,6 24,1 23,2 Unemployed 4,6 56, 47, On Social benefits 28,1 4,9 18,5 Others (begging, stealing...) 8,8 15, 11,3 Ever in prison 67,8 58,9 64,1,12 * Last 6 months

Spanish n=439 Immigrants n=39 Total Accommodation (last 6 months) <,1 Own house 49,9 25,6 39,8 Hostel 8,9 15,2 11,5 House with other people 8,9 7,1 8,2 Without a fixed place 19,1 35,3 25,8 Prison 1,8 2,6 2,1 Squatted house 8, 11,3 9,4 Others 3,4 2,9 3,2 Living with (last 6 months):* Alone 29,8 48,9 37,7 <,1 Partner 24,1 23,1 23,7 ns Parents or relatives 35,8 7,8 24,2 <,1 Children 11,4 3,2 8, <,1 Friends or other adults 17,1 32,8 23,6 <,1 p * Non mutually exclusive categories

Drug consumption characteristics: Spanish n=439 Immigrants n=39 Total p Ever in treatment 93,6 74,4 85,7 <,1 Meant time of drug injection (DE) 18,1 (8,7) 1,8 (6,7) 15,1 <,1 Most often drug injected** <,1 Heroin 41,3 4,3 4,9 Cocaine 42,5 23,1 34,5 Heroin plus cocaine 16,2 35,7 24, Others* -,9,6 Injecting daily** 43,7 57,6 49,5 <,1 methadone, amphetamine, ketamine, morphine, buprenorphine, LSD, MDMA ** Last 6 months

Syringe sharing prevalences 1 9 8 P<,1 Spanishs Immigrants 7 6 5 57,5 42,9 51,5 Total 4 3 2 19,5 19,2 19,4 23,3 22,3 22,9 1 Has ever shared Has accepted syringes (last 6 months) Has passed syringes (last 6 months)

Indirect sharing prevalences (Last 6 months)* 1 9 8 7 27 with a used syringe * p>,5 Spanishs Immigranst Total 6 5 49,9 5 49,9 54,9 52,6 54 4 3 2 1 Front/backloading Sharing other m aterial

Most usual places were syringes are obtained (last 6 months) 1 9 8 p<,5 Potentially non sterile sources 7 6 5 4 3 p<,5 2 1 Buying in pharmacy Most used source for 58 of Spaniards outreach worker NSP Consumption rooms Drug treat. or health facilities Colleagues Partner Drug dealer Most used source for 56 of immigrants Spanish Immigrants

Sexual behaviour (Last 6 months): Spanish n=439 Immigrants n=39 Total p Has had sexual intercourse 67,4 72,8 69,7 ns Heterosexual (stable partner) 47,2 5, 48,3 ns With UDI stabel partner* 41,5 44,2 42,6 ns With HIV + stable partner* 24,9 4, 16, <,1 Heterosexual (occasional partners) 31,9 37,9 34,4 ns Sex with clients 8,5 5,8 7,4 ns Homosexual 2,7 3,6 3,1 ns * base: 27 Spanish and 154 immigrants with stable partner

Use of condoms by type of sexual partner (Last 6 months) p>,5 1 9 8 7 6 5 4 3 2 1 Last sexual intercourse Stable partner Last 6 months sexual interc. p>,5 1 9 8 7 6 5 4 3 2 1 Last sexual interc. Occasional partner Last 6 month sexual interc. Spanish Immigrants Total 1 Clients 8 6 4 2 p>,5 Last sexual interc. Last 6 month sexual interc.

Use of health services (last 6 months)* ITS centre Family planning centre Hospital Immigrants Spanish Private doctor Drug treatment Prison A&E rooms GP 1 2 3 4 5 6 7 8 9 1 p<,5 * categorías no excluyentes

Prevalence of HIV, HVC and STI (biological samples)

By country Spanish Immigrants Total 1 HIV p<,1 1 HCV p=,818 8 8 75,2 74,4 74,9 6 4 2 43 22,4 34,5 6 4 2 2 Chlamydia trachomatis p=,49 1 Neisseria gonorrhoeae p=,41 15 8 1 6 4 5 1,4 3,6 2,6 2,9,3,7

By country and sex Sanish Men Spanish Women Immig. Men Immig. Women 1 HIV 1 HCV 8 6 4 2 4,4 52,6 22,5 21,6 8 6 4 2 75,5 74 76,1 62,2 P<,5 No sign No sign P=,6 3 STI urine 25 2 15 1 5,9 6,3 3,3 8,1 P<,1 No sign

Conclusiones There is still a high prevalence of HIV, which is higher among Spanish injectors compared to immigrants. HCV prevalence is very high and similar between the two groups. Immigrants are younger with a shorter injecting career. They have a smaller social network and lower contact with health and drug services apart from harm reduction services. All these may increase their vulnerability to acquire these infections Health and drug treatment services should be more sensitive to the new cultural and ethnic diversity of our society Low prevalence of STI among this population, higher in immigrants. However condom use is low More and better sexual prevention education should be done, especially regarding condom use among stable partners HIV transmission is mainly by risk injecting behaviour We should still expand and improve our harm reduction strategies

Acknowledges REDAN WORKING GROUP CEEISCAT: Jordi Casabona, Cinta Folch; Anna Esteve, Alexandra Montoliu; Rafa Muñoz Servei Microbiologia HUGTiP: Victoria González, Elisabeth Bascuñana, Vicenç Ausina Agència de Salut Pública de Barcelona: M. Teresa Brugal, Albert Espelt, Carmen Vecino Sudirecció General de Drogodependències: Xavier Majó, Joan Colom Àmbit Prevenció: Mercè Meroño, Anna Altabas Harm reduction services: Barcelona: Sant Adrià del Besós L Hospitalet de L: Sta Coloma de G Badalona: Reus: Terrassa: Lleida: Constantí: Girona: Àmbit Prevenció (AP), SAPS, Baluard, CAS Vall d Hebrón; El Local Sant Adrià; AEC-Gris ASAUPA M CAS, ARSU AIDE, Alba Arrels, F Mercè Fontanilles Creu Roja IAS Interviewers: Carmen Stanescu; Constanza Daigre; Pau Freixa; Alba Mestres; Silvia Isabel Moreira; Fabio Boccali; Pedro Sánchez; Rosa Kistmacher; Karla Cornejero; Sebastián Riveros; Esteve Lafita; Marc Muñoz; Marta Pardell; Joan Obiols; Concepció Escué